Adaptin Bio APTN
OTC APTN
$6.27 +0.02 (+0.32%)
At close: Aug 3, 2026 · 4:00 PM UTC

Adaptin Bio (APTN) Times Interest Earned (2023 - 2026)

Adaptin Bio (APTN) posted Times Interest Earned of -$588.86 for Q1 2026, down 4930.93% sequentially from -$11.7 in Q1 2025, and down 4930.93% YoY from $12.19 in Q1 2025.

Adaptin Bio (APTN) Times Interest Earned (2023 - 2026) Analysis & Trends

Adaptin Bio has reported Times Interest Earned for 4 years, with the latest figure at -$588.86 in Q1 2026.

  • Quarterly Times Interest Earned fell 4930.93% year-over-year to -$588.86 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2938.1 (down 35125.68% YoY) and the FY2025 annual result came in at -$2.68, up 16.62% from the prior year.
  • Times Interest Earned slipped to -$588.86 in Q1 2026 per APTN's latest filing, from -$11.7 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$0.96 in Q4 2023 and troughed at -$588.86 in Q1 2026.
  • A 4-year average of -$91.08 and a median of -$9.34 in 2024 frame the typical range for Times Interest Earned.
  • The sharpest annual moves came in 2025 and 2026: Times Interest Earned tumbled 54.49% in 2025, then sank 4930.93% in 2026.
  • Over 4 years, Times Interest Earned stood at -$0.96 in 2023, then plunged by 261.27% to -$3.48 in 2024, then slumped by 236.08% to -$11.7 in 2025, then tumbled by 4930.93% to -$588.86 in 2026.
  • According to Business Quant data, Times Interest Earned over the past three periods registered -$588.86, -$11.7, and -$3.48 for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -255.67
Mar 31, 2026 -588.86
Mar 31, 2025 -11.70
Dec 31, 2024 -3.48
Sep 30, 2024 -9.34
Jun 30, 2024 -15.65
Mar 31, 2024 -7.58
Dec 31, 2023 -0.96